+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunoglobulin"

78 kda Glucose Regulated Protein - Pipeline Review, H2 2019 - Product Thumbnail Image

78 kda Glucose Regulated Protein - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 47 Pages
  • Global
From
Biologics Markets in China - Product Thumbnail Image

Biologics Markets in China

  • Report
  • June 2023
  • 243 Pages
  • China
From
From
China Blood Product Industry Report, 2020-2027 - Product Thumbnail Image

China Blood Product Industry Report, 2020-2027

  • Report
  • March 2021
  • 180 Pages
  • China
From
Humira - Product Thumbnail Image

Humira

  • Report
  • August 2018
  • 94 Pages
  • Global
From
Enbrel - Product Thumbnail Image

Enbrel

  • Report
  • May 2018
  • 61 Pages
  • Global
From
Loading Indicator

The Immunoglobulin market is a segment of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Immunoglobulin (Ig) is a type of protein found in the blood that helps fight infection and disease. It is used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and infections. Immunoglobulin therapies are typically administered intravenously or subcutaneously, and can be used to replace or supplement the body's natural Ig production. The Immunoglobulin market is highly competitive, with a number of companies offering a range of products. These products vary in terms of dosage, delivery method, and cost. Companies in the market are focused on developing new therapies and improving existing ones, as well as expanding their product portfolios. Some of the major companies in the Immunoglobulin market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Show Less Read more